Presentation is loading. Please wait.

Presentation is loading. Please wait.

Hair Disorders GHADA BINSAIF, MD Associate professor & Consultant Dermatologist Hair and Aesthetic specialist.

Similar presentations


Presentation on theme: "Hair Disorders GHADA BINSAIF, MD Associate professor & Consultant Dermatologist Hair and Aesthetic specialist."— Presentation transcript:

1 Hair Disorders GHADA BINSAIF, MD Associate professor & Consultant Dermatologist Hair and Aesthetic specialist

2 Objective  Normal anatomy of hair follicle and hair cycle  Causes, features and management of non scarring alopecia, Particularly: Alopecia areata Androgenetic alopecia Telogen effluvium Anagen effluvium  Causes and features of scarring alopecia

3

4

5 Hair Types  Vellous  Terminal  Androgen dependant terminal

6 Hair Cycle Hair growth is very dynamic

7 How many hairs in the body? 5 millions hairs in the body 100,000 in the scalp Growth rate? 0.3mm/day for scalp hair

8 Alopecia Scaring (Irreversible) None Scaring (Reversible)

9

10 Alopecia Areata

11 Sudden hair loss ( localized or generalized) Alopecia Areata affects up to 2% 75% : Self recovery, 2-6 m Causes : 30%: +ve Family history autoimmune

12 Clinical findings  Well demarcated  Exclamation point  Normal scalp  Nail: pitting, ridges

13

14 Types of alopecia areata - Localized partial - Localized extensive - Alopecia ophiasis - Alopecia totalis - Alopecia universalis

15

16

17 Diagnosis  Clinically  H/E: sworm bees

18 Treatment 1. Observation 2. Intralesional Corticosteroids 3. Skin Sensitizers Anthraline Diphencyclopropenone (DPCP) others

19 Others  Topical steroids  Systemic Steroids  Cytotoxic Rx  Phototherapy  Minoxidil  Hair Transplant – ( NO)

20 Androgenetic Alopecia (Male and Female Pattern Hair Loss)

21  Androgen dependent loss of scalp hair  Androgenetic Alopecia affects up to 50% of males and 40% of females  Autosomal dominant with variable penetrance  85% : +ve family history

22 5 ALPHA Reductase Testosterone DihydorTestosterone (Active) Miniaturization of Terminal Hairs

23 Male Pattern Hair Loss

24

25 Female Pattern Hair Loss

26

27 Treatment  Topical: Neoxidil 2%- 5% solution  Systemic: Fenastride Spironolactone

28 Telogen effluvium Chronic alopecia Reversible (but may be become chronic) 3-4 months

29 Causes

30 Treatment  Remove or treat the cause  Minoxidil 2% Solution

31 Anagen effluvium  Always related to cytotoxic chemotherapy  Acute and severe alopecia  Mostly reversible but not always

32 Scarring Alopecia  SLE — DLE  LP  Sarcoidosis  Leprosy  Kerion - Favus  Trauma

33

34

35


Download ppt "Hair Disorders GHADA BINSAIF, MD Associate professor & Consultant Dermatologist Hair and Aesthetic specialist."

Similar presentations


Ads by Google